更新 2024.2.22
このエントリーをはてなブックマークに追加

MANUAL

TOP PAGE

LINK

Kids-Hero Research Institute.

<< 4521
科研製薬

LIST

4524
仁丹
>>

Eisai Co., Ltd. (4523:TYO-JP)

4523

       
Company INFORMATION
  Trading Symbol 4523
  Website http://www.eisai.co.jp/
  Sector Health Care
  Location 東京都文京区小石川4-6-10
  Employees 3,043 人
  Revenue 695,621百万円
  Description  
  The Eisai Group is primarily engaged in the research and development, manufacturing and marketing of pharmaceutical products. The company is comprised of two business segments. The pharmaceuticals business is engaged in research and development, manufacturing and sales of ethical drugs, generic drugs, over-the-counter drugs and other products. In the Pharmaceuticals segment, the company operates in five regions: Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Oceania), and Asia and Latin America (South Korea, Taiwan, Hong Kong, India, ASEAN, Latin America, etc.). Other businesses include licensing revenues and businesses related to pharmaceutical raw materials, etc. Neurology and oncology are the company's focus areas, with brands such as the anticancer drugs Lembima and Halaven.
Highly correlated Stock
  9735 セコム(株)   9069 センコーグループホールディングス(株)   4503 アステラス製薬(株)   7965 象印マホービン(株)   8200 (株)リンガーハット   8279 (株)ヤオコー   9600 (株)アイネット   9058 トランコム(株)   9045 京阪ホールディングス(株)   9830 トラスコ中山(株)   1944 (株)きんでん   9619 (株)イチネンホールディングス   2331 綜合警備保障(株)   2594 キーコーヒー(株)   4768 (株)大塚商会   9543 静岡ガス(株)  
Other Websites
  KHRI(japanese site)   market.ft.com   GOOGLE FINANCE   STOCKOPEDIA   MARKET WATCH   BARRON'S   CNBC   REUTERS   WSJ   TRADING ECONOMICS  

URL of Eisai Co., Ltd. (4523:TYO-JP)
http://kids-hero.main.jp/japan_market/code4523.html

We are now in an age when the term “Artificial intelligence” is used as a matter of course. The purpose of KHRI's AI(Artificial intelligence) is to stabilize economic activity, so it is designed specifically to analyze and predict economic activity, and never harm humans. AI System Inference Algorithm Performs Parameter Optimization Using Past Economic Activity Data.

To the TOP


[SITE BROWSING CONDITIONS] IMPORTANT!
Browsing of this site requires your understanding and consent to all of the contents described below. If you do not agree to the following items, you are prohibited from browsing this site. Please stop browsing immediately.
This site is intended to contribute to research activities in the field of information technology and to stabilize the economy through such activities, and is NOT INTENDED to sell or solicit financial products. Permission is granted to view this site for research activities only. Viewing this site is at the visitor's own risk. The Administrator of this web site is not responsible for any damages or problems caused by your use of the information provided by this site for research activities. The Administrator of this web site reserves the right to update, change, delete, or discontinue publication of information on this site without prior notice. Although every effort has been made to ensure the accuracy of the information posted on this site, incorrect information may be posted against the administrator's intention due to malfunction of equipment or artificial alteration by a third party. Please use the data and information for your research activities at your own discretion. The data and information on this site is intended to be used for research activities. And the data and information is caluculated automatically generated by KHRI original mathematical algorithm. Therefore, we do not intentionally manipulate information on specific stocks. Due to the convenience of processing, the stock prices posted on this site are not the latest stock prices, and there is a time lag. Please check the update date of each page.
All copyrights to the information on this site (including logos, images, and text) belong to the Kids-Hero Research Institute and information providers. Any diversion, duplication, sale, etc. of the information posted on this site is strictly prohibited.




Copyright (c) Kids-Hero Research Institute. All Rights Reserved.